EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The assessment of trabecular bone score to improve the sensitivity of FRAX in patients with type 2 diabetes mellitus

Tatiana O. Yalochkina, Zhanna E. Belaya, Tatiana O. Chernova, Natalia I. Sazonova, Natalya V. Tarbaeva, Timur T. Tsoriev, Liudmila Y. Rozhinskaya, Galina A. Melnichenko

Osteoporosis and Bone Diseases · 2020

DOI: 10.14341/osteo12464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoporosis and Bone Diseases, 2020. Verfasst von Tatiana O. Yalochkina und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To estimate the trabecular bone score (TBS) for evaluation of fracture probability in order to make decisions about starting osteoporosis treatment in patients with type 2 diabetes mellitus (T2DM). Materials and methods. We obtained the bone mineral density (BMD) and trabecular bone score (TBS) using dual energy X-ray absorptiometry (iDXA) in patients with T2DM (with and without a history of osteoporotic fractures) versus the control group. Before and after TBS measurements we assessed the ten-year probability of fracture using the Fracture Risk Assessment Tool (FRAX).

Results

We enrolled 48 patients with T2DM, including 17 with a history of low-traumatic fracture, 31 patients without fractures and 29 subjects of a control group. BMD was higher in patients with T2DM compared to the control group at L1L4 (mean T-score 0.44, 95% CI -3.2 4.9 vs mean T-score 0.33, 95% CI -2.9 3.0 in a control group p=0.052) and Total Hip (mean T-score 0.51, 95% CI -2.1 3.0 vs mean T-score -0.03, 95% CI -1.4 1.2 in a control group p=0,025). The TBS and 10-year probability of fracture (FRAX) was not different in patients with T2DM versus the control group. However, when the TBS was entered as an additional risk factor, the 10-year probability of fracture became higher in patients with T2DM (10-year probability of fracture in T2DM- 8.68, 95% CI 0.3-25.0 versus 6.68, 95% CI 0.415.0 in control group, p=0.04). Among patients with diabetes with and without fractures the FRAX score was higher in subjects with fractures, but no difference was found in regards to BMD or TBS. Entering BMD and TBS values into the FRAX tool in subjects with diabetes and fractures decreased the FRAX score. However, patients with low-traumatic fractures should be treated for osteoporosis without a BMD, TBS or FRAX assessment.

Conclusion

TBS improves the results of FRAX assessment in patients with T2DM and should be entered while evaluating FRAX in patients with T2DM. However, additional research is needed to develop a more sensitive tool to evaluate fracture risk in patients with T2DM.

Zitieren

APA

Yalochkina, T. O., Belaya, Z. E., Chernova, T. O., Sazonova, N. I., Tarbaeva, N. V., Tsoriev, T. T., Rozhinskaya, L. Y., & Melnichenko, G. A. (2020). The assessment of trabecular bone score to improve the sensitivity of FRAX in patients with type 2 diabetes mellitus. Osteoporosis and Bone Diseases. https://doi.org/10.14341/osteo12464

Vancouver

Yalochkina TO, Belaya ZE, Chernova TO, Sazonova NI, Tarbaeva NV, Tsoriev TT, et al. The assessment of trabecular bone score to improve the sensitivity of FRAX in patients with type 2 diabetes mellitus. Osteoporosis and Bone Diseases. 2020. doi:10.14341/osteo12464

BibTeX
@article{Yalochkina2020,
  author = {Yalochkina, Tatiana O. and Belaya, Zhanna E. and Chernova, Tatiana O. and Sazonova, Natalia I. and Tarbaeva, Natalya V. and Tsoriev, Timur T. and Rozhinskaya, Liudmila Y. and Melnichenko, Galina A.},
  title = {The assessment of trabecular bone score to improve the sensitivity of FRAX in patients with type 2 diabetes mellitus},
  journal = {Osteoporosis and Bone Diseases},
  year = {2020},
  doi = {10.14341/osteo12464}
}
Kostenlos starten →